_id

69147e6dccc777a4e85d9209

Ticker

NAMSW

Name

NewAmsterdam Pharma Company N.V. Warrant

Exchange

NASDAQ

Address

Gooimeer 2-35, Naarden, Netherlands, 1411 DC

Country

USA

Sector

Industry

Currency

USD

Website

https://www.newamsterdampharma.com

Description

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.

Last Close

23.5

Volume

220

Current Price

23.95

Change

0.1

Last Updated

2026-01-05T11:10:18.133Z

Image

data:image/webp;base64,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

Ipo Date

2022-11-23T00:00:00.000Z

Market Cap

-

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Rating

-

Target Price

-

Strong Buy

-

Buy

-

Hold

-

Sell

-

Strong Sell

-

Current Quarter

2025-09-30

Revenue

348000

Cost Of Revenue

64000

Gross Profit

348000

Operating Expenses

55491000

Operating Income

-55143000

Interest Expense

-

Pretax Income

-72005000

Net Income

-72005000

Eps

-0.6050826810756876

Dividends Per Share

-

Shares Outstanding

0

Income Tax Expense

-

EBITDA

-71941000

Operating Margin

-15845.689655172413

Total Other Income Expense Net

-16862000

Cash

538407000

Short Term Investments

164539000

Receivables

20249000

Inventories

-

Total Current Assets

732328000

Property Plant Equipment

569000

Total Assets

786427000

Payables

3632000

Short Term Debt

181000

Long Term Debt

-

Total Liabilities

58357000

Equity

728070000

Bs_currency_symbol

USD

Depreciation

64000

Change In Working Capital

-10351000

Cash From Operations

-32769000

Capital Expenditures

42000

Cash From Investing

2506000

Cash From Financing

5892000

Net Change In Cash

-24149000

Cf_currency_symbol

USD

PE

-

PB

3.9145361994039036

ROE

-9.889845756589338

ROA

-9.155967432450819

FCF

-32811000

Fcf Percent

-94.28448275862068

Piotroski FScore

1

Health Score

30

Deep Value Investing Score

2.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.8

Garp Investing Score

2.5

Growth Investing Score

1

Momentum Investing Score

3.5

Net Net Investing Score

2

Quality Investing Score

2.5

Value Investing Score

3.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

348000

Quarters > 0 > income Statement > cost Of Revenue

64000

Quarters > 0 > income Statement > gross Profit

348000

Quarters > 0 > income Statement > operating Expenses

55491000

Quarters > 0 > income Statement > operating Income

-55143000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-72005000

Quarters > 0 > income Statement > net Income

-72005000

Quarters > 0 > income Statement > eps

-0.6050826810756876

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

119000266

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-71941000

Quarters > 0 > income Statement > operating Margin

-15845.689655172413

Quarters > 0 > income Statement > total Other Income Expense Net

-16862000

Quarters > 0 > income Statement > currency_symbol

USD

Quarters > 0 > balance Sheet > cash

538407000

Quarters > 0 > balance Sheet > short Term Investments

164539000

Quarters > 0 > balance Sheet > receivables

20249000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

732328000

Quarters > 0 > balance Sheet > property Plant Equipment

569000

Quarters > 0 > balance Sheet > total Assets

786427000

Quarters > 0 > balance Sheet > payables

3632000

Quarters > 0 > balance Sheet > short Term Debt

181000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

58357000

Quarters > 0 > balance Sheet > equity

728070000

Quarters > 0 > balance Sheet > currency_symbol

USD

Quarters > 0 > cash Flow > net Income

39527000

Quarters > 0 > cash Flow > depreciation

64000

Quarters > 0 > cash Flow > change In Working Capital

-10351000

Quarters > 0 > cash Flow > cash From Operations

-32769000

Quarters > 0 > cash Flow > capital Expenditures

42000

Quarters > 0 > cash Flow > cash From Investing

2506000

Quarters > 0 > cash Flow > cash From Financing

5892000

Quarters > 0 > cash Flow > net Change In Cash

-24149000

Quarters > 0 > cash Flow > currency_symbol

USD

Quarters > 0 > ratios > PE

-0.6050826810756876

Quarters > 0 > ratios > PB

3.9145361994039036

Quarters > 0 > ratios > ROE

-9.889845756589338

Quarters > 0 > ratios > ROA

-9.155967432450819

Quarters > 0 > ratios > FCF

-32811000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-94.28448275862068

Quarters > 0 > health Score

30

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

19145000

Quarters > 1 > income Statement > cost Of Revenue

45000

Quarters > 1 > income Statement > gross Profit

19145000

Quarters > 1 > income Statement > operating Expenses

54780000

Quarters > 1 > income Statement > operating Income

-35635000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-17364000

Quarters > 1 > income Statement > net Income

-17364000

Quarters > 1 > income Statement > eps

-0.1543330661509527

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

112509914

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-35590000

Quarters > 1 > income Statement > operating Margin

-186.1321493862627

Quarters > 1 > income Statement > total Other Income Expense Net

18271000

Quarters > 1 > income Statement > currency_symbol

USD

Quarters > 1 > balance Sheet > cash

563864000

Quarters > 1 > balance Sheet > short Term Investments

175298000

Quarters > 1 > balance Sheet > receivables

19750000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

769850000

Quarters > 1 > balance Sheet > property Plant Equipment

620000

Quarters > 1 > balance Sheet > total Assets

815112000

Quarters > 1 > balance Sheet > payables

5895000

Quarters > 1 > balance Sheet > short Term Debt

225000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

36615000

Quarters > 1 > balance Sheet > equity

778497000

Quarters > 1 > balance Sheet > currency_symbol

USD

Quarters > 1 > cash Flow > net Income

-17364000

Quarters > 1 > cash Flow > depreciation

45000

Quarters > 1 > cash Flow > change In Working Capital

-23843000

Quarters > 1 > cash Flow > cash From Operations

-37671000

Quarters > 1 > cash Flow > capital Expenditures

88000

Quarters > 1 > cash Flow > cash From Investing

-159136000

Quarters > 1 > cash Flow > cash From Financing

3425000

Quarters > 1 > cash Flow > net Change In Cash

-184556000

Quarters > 1 > cash Flow > currency_symbol

USD

Quarters > 1 > ratios > PE

-0.1543330661509527

Quarters > 1 > ratios > PB

3.46130099448039

Quarters > 1 > ratios > ROE

-2.2304517551127367

Quarters > 1 > ratios > ROA

-2.1302593999352237

Quarters > 1 > ratios > FCF

-37759000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-1.9722642987725254

Quarters > 1 > health Score

29

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

2978000

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

2978000

Quarters > 2 > income Statement > operating Expenses

71903000

Quarters > 2 > income Statement > operating Income

-68925000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-39527000

Quarters > 2 > income Statement > net Income

-39527000

Quarters > 2 > income Statement > eps

-0.34038338068994156

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

116124941

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-68873000

Quarters > 2 > income Statement > operating Margin

-2314.4728005372735

Quarters > 2 > income Statement > total Other Income Expense Net

29398000

Quarters > 2 > income Statement > currency_symbol

USD

Quarters > 2 > balance Sheet > cash

748420000

Quarters > 2 > balance Sheet > short Term Investments

60057000

Quarters > 2 > balance Sheet > receivables

1613000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

817304000

Quarters > 2 > balance Sheet > property Plant Equipment

607000

Quarters > 2 > balance Sheet > total Assets

818413000

Quarters > 2 > balance Sheet > payables

6087000

Quarters > 2 > balance Sheet > short Term Debt

252000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

41050000

Quarters > 2 > balance Sheet > equity

777363000

Quarters > 2 > balance Sheet > currency_symbol

USD

Quarters > 2 > cash Flow > net Income

-39527000

Quarters > 2 > cash Flow > depreciation

52000

Quarters > 2 > cash Flow > change In Working Capital

10351000

Quarters > 2 > cash Flow > cash From Operations

-36468000

Quarters > 2 > cash Flow > capital Expenditures

16000

Quarters > 2 > cash Flow > cash From Investing

2855000

Quarters > 2 > cash Flow > cash From Financing

6519000

Quarters > 2 > cash Flow > net Change In Cash

-23323000

Quarters > 2 > cash Flow > currency_symbol

USD

Quarters > 2 > ratios > PE

-0.34038338068994156

Quarters > 2 > ratios > PB

3.5777266694581553

Quarters > 2 > ratios > ROE

-5.084754484069862

Quarters > 2 > ratios > ROA

-4.8297131155052515

Quarters > 2 > ratios > FCF

-36484000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-12.251175285426461

Quarters > 2 > health Score

30

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

12772000

Quarters > 3 > income Statement > cost Of Revenue

51000

Quarters > 3 > income Statement > gross Profit

12772000

Quarters > 3 > income Statement > operating Expenses

56001000

Quarters > 3 > income Statement > operating Income

-43229000

Quarters > 3 > income Statement > interest Expense

3205000

Quarters > 3 > income Statement > pretax Income

-92177000

Quarters > 3 > income Statement > net Income

-92177000

Quarters > 3 > income Statement > eps

-0.950000000515313

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

97028421

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-111693000

Quarters > 3 > income Statement > operating Margin

-338.46695897275293

Quarters > 3 > income Statement > total Other Income Expense Net

-48948000

Quarters > 3 > income Statement > currency_symbol

USD

Quarters > 3 > balance Sheet > cash

771743000

Quarters > 3 > balance Sheet > short Term Investments

62447000

Quarters > 3 > balance Sheet > receivables

21305000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

863413000

Quarters > 3 > balance Sheet > property Plant Equipment

673000

Quarters > 3 > balance Sheet > total Assets

864620000

Quarters > 3 > balance Sheet > payables

4744000

Quarters > 3 > balance Sheet > short Term Debt

246000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

107120000

Quarters > 3 > balance Sheet > equity

757500000

Quarters > 3 > balance Sheet > currency_symbol

USD

Quarters > 3 > cash Flow > net Income

-92177000

Quarters > 3 > cash Flow > depreciation

51000

Quarters > 3 > cash Flow > change In Working Capital

-7980000

Quarters > 3 > cash Flow > cash From Operations

-37481000

Quarters > 3 > cash Flow > capital Expenditures

3000

Quarters > 3 > cash Flow > cash From Investing

-62179000

Quarters > 3 > cash Flow > cash From Financing

456611000

Quarters > 3 > cash Flow > net Change In Cash

349014000

Quarters > 3 > cash Flow > currency_symbol

USD

Quarters > 3 > ratios > PE

-0.950000000515313

Quarters > 3 > ratios > PB

3.067763277821782

Quarters > 3 > ratios > ROE

-12.168580858085809

Quarters > 3 > ratios > ROA

-10.660984016099558

Quarters > 3 > ratios > FCF

-37484000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-2.9348575007829627

Quarters > 3 > health Score

30

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

45563000

Annuals > 0 > income Statement > cost Of Revenue

113000

Annuals > 0 > income Statement > gross Profit

45563000

Annuals > 0 > income Statement > operating Expenses

221852000

Annuals > 0 > income Statement > operating Income

-176289000

Annuals > 0 > income Statement > interest Expense

0

Annuals > 0 > income Statement > pretax Income

-241599000

Annuals > 0 > income Statement > net Income

-241598000

Annuals > 0 > income Statement > eps

-2.5604382082138244

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

94358067

Annuals > 0 > income Statement > income Tax Expense

-1000

Annuals > 0 > income Statement > EBITDA

-241486000

Annuals > 0 > income Statement > operating Margin

-386.91262647323487

Annuals > 0 > income Statement > total Other Income Expense Net

-65310000

Annuals > 0 > income Statement > currency_symbol

USD

Annuals > 0 > balance Sheet > cash

771743000

Annuals > 0 > balance Sheet > short Term Investments

62447000

Annuals > 0 > balance Sheet > receivables

21305000

Annuals > 0 > balance Sheet > inventories

-

Annuals > 0 > balance Sheet > total Current Assets

863413000

Annuals > 0 > balance Sheet > property Plant Equipment

673000

Annuals > 0 > balance Sheet > total Assets

864620000

Annuals > 0 > balance Sheet > payables

4744000

Annuals > 0 > balance Sheet > short Term Debt

246000

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

107120000

Annuals > 0 > balance Sheet > equity

757500000

Annuals > 0 > balance Sheet > currency_symbol

USD

Annuals > 0 > cash Flow > net Income

-241598000

Annuals > 0 > cash Flow > depreciation

113000

Annuals > 0 > cash Flow > change In Working Capital

-32674000

Annuals > 0 > cash Flow > cash From Operations

-158564000

Annuals > 0 > cash Flow > capital Expenditures

672000

Annuals > 0 > cash Flow > cash From Investing

-62848000

Annuals > 0 > cash Flow > cash From Financing

659507000

Annuals > 0 > cash Flow > net Change In Cash

431293000

Annuals > 0 > cash Flow > currency_symbol

USD

Annuals > 0 > ratios > PE

-2.5604382082138244

Annuals > 0 > ratios > PB

2.877453924356436

Annuals > 0 > ratios > ROE

-31.894125412541253

Annuals > 0 > ratios > ROA

-27.942680021281024

Annuals > 0 > ratios > FCF

-159236000

Annuals > 0 > ratios > Piotroski FScore

0

Annuals > 0 > ratios > fcf Percent

-3.494853280073744

Annuals > 0 > health Score

34

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

14090000

Annuals > 1 > income Statement > cost Of Revenue

44394

Annuals > 1 > income Statement > gross Profit

14090000

Annuals > 1 > income Statement > operating Expenses

197057000

Annuals > 1 > income Statement > operating Income

-182967000

Annuals > 1 > income Statement > interest Expense

6799141

Annuals > 1 > income Statement > pretax Income

-176910000

Annuals > 1 > income Statement > net Income

-176937000

Annuals > 1 > income Statement > eps

-2.153514943096048

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

82161956

Annuals > 1 > income Statement > income Tax Expense

27000

Annuals > 1 > income Statement > EBITDA

-176861000

Annuals > 1 > income Statement > operating Margin

-1298.5592618878638

Annuals > 1 > income Statement > total Other Income Expense Net

6057000

Annuals > 1 > income Statement > currency_symbol

USD

Annuals > 1 > balance Sheet > cash

340450000

Annuals > 1 > balance Sheet > short Term Investments

0

Annuals > 1 > balance Sheet > receivables

1881000

Annuals > 1 > balance Sheet > inventories

-1709262.01

Annuals > 1 > balance Sheet > total Current Assets

346791000

Annuals > 1 > balance Sheet > property Plant Equipment

101000

Annuals > 1 > balance Sheet > total Assets

347097000

Annuals > 1 > balance Sheet > payables

16923000

Annuals > 1 > balance Sheet > short Term Debt

60000

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

58704000

Annuals > 1 > balance Sheet > equity

288393000

Annuals > 1 > balance Sheet > currency_symbol

USD

Annuals > 1 > cash Flow > net Income

-176937000

Annuals > 1 > cash Flow > depreciation

49000

Annuals > 1 > cash Flow > change In Working Capital

5866000

Annuals > 1 > cash Flow > cash From Operations

-141218000

Annuals > 1 > cash Flow > capital Expenditures

24000

Annuals > 1 > cash Flow > cash From Investing

-24000

Annuals > 1 > cash Flow > cash From Financing

8912000

Annuals > 1 > cash Flow > net Change In Cash

-127278000

Annuals > 1 > cash Flow > currency_symbol

USD

Annuals > 1 > ratios > PE

-2.153514943096048

Annuals > 1 > ratios > PB

6.581093104201559

Annuals > 1 > ratios > ROE

-61.35273741040871

Annuals > 1 > ratios > ROA

-50.97624007121928

Annuals > 1 > ratios > FCF

-141242000

Annuals > 1 > ratios > Piotroski FScore

0

Annuals > 1 > ratios > fcf Percent

-10.024272533711853

Annuals > 1 > health Score

26

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

102694000

Annuals > 2 > income Statement > cost Of Revenue

70703

Annuals > 2 > income Statement > gross Profit

102694000

Annuals > 2 > income Statement > operating Expenses

106251000

Annuals > 2 > income Statement > operating Income

-3557000

Annuals > 2 > income Statement > interest Expense

287000

Annuals > 2 > income Statement > pretax Income

-22634000

Annuals > 2 > income Statement > net Income

-22634000

Annuals > 2 > income Statement > eps

-1.1933839267519357

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

18966235

Annuals > 2 > income Statement > income Tax Expense

70832000

Annuals > 2 > income Statement > EBITDA

-22338000

Annuals > 2 > income Statement > operating Margin

-3.463688238845502

Annuals > 2 > income Statement > total Other Income Expense Net

-19077000

Annuals > 2 > income Statement > currency_symbol

EUR

Annuals > 2 > balance Sheet > cash

467728000

Annuals > 2 > balance Sheet > short Term Investments

-

Annuals > 2 > balance Sheet > receivables

2070000

Annuals > 2 > balance Sheet > inventories

21500

Annuals > 2 > balance Sheet > total Current Assets

477979000

Annuals > 2 > balance Sheet > property Plant Equipment

154000

Annuals > 2 > balance Sheet > total Assets

478497000

Annuals > 2 > balance Sheet > payables

11853000

Annuals > 2 > balance Sheet > short Term Debt

66000

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

48431000

Annuals > 2 > balance Sheet > equity

430066000

Annuals > 2 > balance Sheet > currency_symbol

EUR

Annuals > 2 > cash Flow > net Income

-22634000

Annuals > 2 > cash Flow > depreciation

9000

Annuals > 2 > cash Flow > change In Working Capital

10373000

Annuals > 2 > cash Flow > cash From Operations

10665000

Annuals > 2 > cash Flow > capital Expenditures

221000

Annuals > 2 > cash Flow > cash From Investing

-221000

Annuals > 2 > cash Flow > cash From Financing

391905000

Annuals > 2 > cash Flow > net Change In Cash

407597000

Annuals > 2 > cash Flow > currency_symbol

EUR

Annuals > 2 > ratios > PE

-1.1933839267519357

Annuals > 2 > ratios > PB

1.0187274243953255

Annuals > 2 > ratios > ROE

-5.262913134263114

Annuals > 2 > ratios > ROA

-4.730228193698184

Annuals > 2 > ratios > FCF

10444000

Annuals > 2 > ratios > Piotroski FScore

2

Annuals > 2 > ratios > fcf Percent

0.10170019670087833

Annuals > 2 > health Score

44

Annuals > 3 > quarter

2021-12-31

Annuals > 3 > income Statement > revenue

0

Annuals > 3 > income Statement > cost Of Revenue

14558

Annuals > 3 > income Statement > gross Profit

-14558

Annuals > 3 > income Statement > operating Expenses

34977000

Annuals > 3 > income Statement > operating Income

-34977000

Annuals > 3 > income Statement > interest Expense

411000

Annuals > 3 > income Statement > pretax Income

-41785000

Annuals > 3 > income Statement > net Income

-41785000

Annuals > 3 > income Statement > eps

-2.3539518900343643

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

17751000

Annuals > 3 > income Statement > income Tax Expense

216000

Annuals > 3 > income Statement > EBITDA

-41369000

Annuals > 3 > income Statement > operating Margin

-

Annuals > 3 > income Statement > total Other Income Expense Net

-6808000

Annuals > 3 > income Statement > currency_symbol

EUR

Annuals > 3 > balance Sheet > cash

60379848

Annuals > 3 > balance Sheet > short Term Investments

-

Annuals > 3 > balance Sheet > receivables

4857226

Annuals > 3 > balance Sheet > inventories

-735

Annuals > 3 > balance Sheet > total Current Assets

66955533

Annuals > 3 > balance Sheet > property Plant Equipment

216081

Annuals > 3 > balance Sheet > total Assets

67988172

Annuals > 3 > balance Sheet > payables

7073809

Annuals > 3 > balance Sheet > short Term Debt

60275

Annuals > 3 > balance Sheet > long Term Debt

-

Annuals > 3 > balance Sheet > total Liabilities

11362447

Annuals > 3 > balance Sheet > equity

56625725

Annuals > 3 > balance Sheet > currency_symbol

EUR

Annuals > 3 > cash Flow > net Income

-41785000

Annuals > 3 > cash Flow > depreciation

5000

Annuals > 3 > cash Flow > change In Working Capital

4470000

Annuals > 3 > cash Flow > cash From Operations

-29512000

Annuals > 3 > cash Flow > capital Expenditures

24000

Annuals > 3 > cash Flow > cash From Investing

-24000

Annuals > 3 > cash Flow > cash From Financing

84704000

Annuals > 3 > cash Flow > net Change In Cash

50485000

Annuals > 3 > cash Flow > currency_symbol

EUR

Annuals > 3 > ratios > PE

-2.3539518900343643

Annuals > 3 > ratios > PB

7.241374834494393

Annuals > 3 > ratios > ROE

-73.79154968876777

Annuals > 3 > ratios > ROA

-61.45921970074441

Annuals > 3 > ratios > FCF

-29536000

Annuals > 3 > ratios > Piotroski FScore

0

Annuals > 3 > ratios > fcf Percent

-

Annuals > 3 > health Score

26

Valuation > metrics > PE

-0.6050826810756876

Valuation > metrics > PB

3.9145361994039036

Valuation > final Score

40.854638005960965

Valuation > verdict

30.5% Overvalued

Profitability > metrics > ROE

-9.889845756589338

Profitability > metrics > ROA

-9.832342884609083

Profitability > metrics > Net Margin

-206.91091954022988

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.08015300726578488

Risk > metrics > Interest Coverage

-861.609375

Risk > final Score

-3386

Risk > verdict

High

Liquidity > metrics > Current Ratio

192.06084447941254

Liquidity > metrics > Quick Ratio

192.06084447941254

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

45.3869900551961

Prev Valuations > 1

44.222733305418444

Prev Valuations > 2

49.32236722178218

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

52

Prev Risks > 1

51

Prev Risks > 2

6

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T22:15:36.164Z